The company will evaluate the Hepzato kit as a combination therapy with the standard of care in patients with liver-dominant ...

The first patient was enrolled in a phase 3 trial for patients with non-metastatic uveal melanoma to either receive Kimmtrak ...

Uveal melanoma is the most common primary malignancy of the eye and frequently leads to metastatic death. Until the mid-20th Century, the only treatment for uveal melanoma was enucleation.

Sweetman now had Stage 4 cancer and he soon learned that treating uveal melanoma liver metastases “was a little tricky.” Doctors gave him chemotherapy for about nine months. It seemed like it ...

Eligible patients were aged 18 years or older with histologically confirmed metastatic uveal melanoma. A two-stage design was used to ensure that the number of patients exposed to an ineffective ...

Delcath Systems (DCTH) announced that the U.S. Food and Drug Administration FDA has completed its 30-day review of the Company’s ...

Glossop's Craig Shore, whose ocular uveal melanoma has mutated to his liver, has been informed the NHS cannot provide chemosaturation. The 52-year-old said he may need to raise at least £120,000 ...

iOnctura has announced promising results from the phase 1 DIONE-01 study, showcasing the clinical activity and long-term safety of roginolisib in patients with uveal melanoma. The data will be ...

In recommending Kimmtrak, NICE factored in a new commercial agreement with the sponsor and changed its 2023 negative opinion.